Abstract Details

Title Clinical Efficacy in Focal Dystonia and Overall Tolerability of NT 201 (Botulinum Neurotoxin Free from Complexing Proteins)

Topic Movement Disorders

Presentation(s) (-)

Poster/Presentation
Number 081

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Susanne Grafe, MD (Merz Pharmaceuticals GmbH)	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file

��ɫ��